Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02365688 · ClinicalTrials.gov registry record · NA
Hemodynamic Response During Goal Directed Fluid Therapy in the OR
A NA study, sponsored by Medtronic - MITG.
- Terminated
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT02365688 is a NA study that was terminated before completion, run by Medtronic - MITG. The registered enrollment target is 18 participants.
The verdict
NCT02365688, a NA study, was terminated before completion, sponsored by Medtronic - MITG.
- TERMINATED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
The purpose of this study is to retrospectively evaluate the hemodynamic response to goal directed fluid therapy fluid during open abdominal surgery where goal directed fluid therapy is a standard of care after establishing a pre-incision baseline response to fluids.
Interventions
- PROCEDURE Initial bolus pre-incision
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2014-09 |
| Est. Completion | 2015-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02365688
The ClinicalTrials.gov registry entry for NCT02365688 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic - MITG, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Initial bolus pre-incision is the first listed.
NCT02365688 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02365688 about?
NCT02365688 is a clinical study titled "Hemodynamic Response During Goal Directed Fluid Therapy in the OR". The purpose of this study is to retrospectively evaluate the hemodynamic response to goal directed fluid therapy fluid during open abdominal surgery where goal directed fluid therapy is a standard of care after establishing a pre-incision baseline response to fluids.
What is the current status of trial NCT02365688?
This trial is currently terminated. It is a NA study. The enrollment target is 18 participants. The study started on 2014-09. Estimated completion is 2015-06.
What interventions are being tested in trial NCT02365688?
The interventions under investigation include: Initial bolus pre-incision (PROCEDURE).
Who is sponsoring clinical trial NCT02365688?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.